Document is current
Any future updates will be listed below
-
Authors
Kim, Hyung-Don
Lee, Jong Seok
Yook, Jeong Hwan
Ryu, Min-Hee
Park, Young-Kyu
Kim, Jin Young
Kim, Young-Woo
Oh, Sang Cheul
Kim, Jong Gwang
Cheong, Jae-Ho
Jeong, Oh
Noh, Sung Hoon
Kang, Yoon-Koo https://orcid.org/0000-0003-0783-6583
- License Information
-
More Information
Article History
Received: 23 June 2021
Accepted: 24 August 2021
First Online: 2 September 2021
Declarations
:
: Nothing directly related to this work. Out of this work, YKK has served as a consultant for ALX Oncology, Zymeworks, Amgen, Novartis, Macrogenics, Daehwa, Blueprint, Surface Oncolgy, BMS, Merck (MSD). MHR received honoraria from DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly, Ono Pharmaceutical, MSD, Taiho Pharmaceutical, Novartis, Daiichi Sankyo and AstraZeneca, and served as a consultant for DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly and Ono Pharmaceutical. JHC is a founder and shareholder of NOVOMICS.
Free to read: This content has been made available to all.
